| 1 |
30619076 | Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS. | 2018 |
1 |
| 2 |
24984169 | Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. | 2014 Sep |
1 |
| 3 |
17046733 | Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. | 2007 Jan |
1 |
| 4 |
15963971 | Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. | 2005 Aug |
1 |
| 5 |
12857466 | [Oxidative stress status in patients with various degrees of chronic renal insufficiency]. | 2003 Feb |
1 |
| 6 |
8642619 | Catalase and superoxide dismutase activities as biomarkers of oxidative stress in workers exposed to mercury vapors. | 1996 Jun 7 |
3 |
| 7 |
8361034 | [Serum superoxide dismutase (SOD) activity in diabetes mellitus]. | 1993 Jun |
1 |
| 8 |
2706418 | Elevation of serum aluminium concentrations in patients with rheumatoid arthritis treated with drugs containing aluminium. | 1989 Apr |
2 |
| 9 |
3685911 | Serum aluminium concentrations in patients with rheumatoid arthritis. | 1987 |
1 |
| 10 |
7151647 | Safety and plasma concentrations of bovine superoxide dismutase administered to human premature infants. | 1982 |
2 |
| 11 |
7172448 | Superoxide dismutase in extracellular fluids. | 1982 Nov 24 |
1 |